What Sustainability Means for Daiichi Sankyo
Guided by our purpose of "Contribute to the enrichment of the quality of life around the world," Daiichi Sankyo has been generating social value by supporting patients and transforming their lives through the development of innovative pharmaceuticals, leveraging our strengths in science and technology.
For the company, sustainability means contributing to a sustainable society through the very core of our business activities. Creating and delivering innovative pharmaceuticals to patients and their families living with disease brings profound hope for the future. By continuing to deliver this hope and advancing sustainable business practices, we contribute to the lives of patients today and for generations to come.
Trust as the Foundation for Lasting Value
Trust from society is essential to our enduring commitment to deliver hope to patients through medicines. The trust we cultivate with all those connected to the company — patients and their families, healthcare professionals, employees, and business partners — forms the foundation of all our business activities, enabling us to be recognized as an indispensable partner by society and to reach more people and deliver meaningful value.
Our 2035 Vision is to be a "Trusted healthcare innovator transforming the lives of people through our science and technology," and being a trusted partner for sustainable society is one of the key strategic pillars in our five-year business plan, covering FY2026 to FY2030.
"No matter how superior a medicine may be, it cannot reach patients without trust." This conviction is embedded in our vision and strategy.
We remain committed to tackling social challenges through our business, delivering hope to patients, and contributing to a sustainable society as a trusted partner.